Related Experiment Video

Updated: Jun 24, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Id2 suppression of p15 counters TGF-beta-mediated growth inhibition of melanoma cells

Natalie C Schlegel1, Ossia M Eichhoff, Silvio Hemmi

  • 1Department of Dermatology, University Hospital of Zürich, Zürich, Switzerland.

Pigment Cell & Melanoma Research
|April 17, 2009
PubMed

Insights

Melanoma cells become aggressive by upregulating Id2, which blocks transforming growth factor beta (TGF-beta) from inhibiting proliferation via p15(Ink4b). This Id2 mechanism promotes melanoma metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Transforming growth factor beta (TGF-beta) resistance is key to malignant progression in many cancers, including melanoma.
  • Melanoma cells exhibit distinct proliferative and invasive subtypes with differential TGF-beta sensitivity.
  • Understanding the molecular mechanisms of TGF-beta resistance is crucial for targeting melanoma aggressiveness.

Purpose of the Study:

  • To investigate the molecular factors that modulate melanoma cell susceptibility to TGF-beta-mediated growth inhibition.
  • To identify key genes involved in the transition of melanoma cells towards a more aggressive, invasive phenotype.

Main Methods:

  • Utilized previously characterized proliferative and invasive melanoma cell lines.
  • Analyzed gene expression patterns, focusing on the Id2 gene and its correlation with TGF-beta response.
  • Investigated the role of Id2 in regulating p15(Ink4b) expression and cell cycle arrest.

Main Results:

  • The Id2 gene was found to be significantly upregulated in invasive melanoma cells resistant to TGF-beta.
  • TGF-beta repressed Id2 expression in proliferative cells, correlating with p15(Ink4b) induction and cell cycle arrest.
  • Ectopic Id2 expression in proliferative cells prevented p15(Ink4b) induction and conferred resistance to TGF-beta.

Conclusions:

  • Upregulation of Id2 is essential for melanoma cells to overcome TGF-beta-mediated growth inhibition.
  • Id2 suppresses TGF-beta-induced p15(Ink4b) expression, facilitating the transition to increased aggressiveness and metastatic potential in melanoma.
  • Targeting the Id2 pathway may offer therapeutic strategies for advanced melanoma.

More Related Videos

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease06:25

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on: March 29, 2024

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...